We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CSTE:NASDAQCaesarstone Ltd. Analysis

Data as of 2026-03-27 - not real-time

$1.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Technical signals are mixed: the price sits above the 20‑day SMA (≈0.92) but below the 50‑ and 200‑day SMAs (≈1.63 and 1.60), RSI is neutral at ~43, and a bullish MACD histogram (+0.08) suggests short‑term upside. Volume is increasing and the market is in a neutral trend, yet the 30‑day volatility is extreme at ~170%, indicating price swings can be large.
Fundamentals are weak: revenue fell 3.5% YoY, margins are deeply negative (operating margin –16%, profit margin –35%), and the company carries a high debt‑to‑equity ratio (~98%). Cash flow is negative, though free cash flow turned modestly positive. The stock trades at a low price‑to‑book (0.25) and price‑to‑sales (0.09), and the DCF model values it at ~1.06, slightly above the current price of $1, implying a modest undervaluation.
Risk profile is elevated: the beta of ~0.9 shows market‑related risk, but the tiny market cap (~$35 M) and thin average volume create liquidity risk. Geographic exposure across Israel, the U.S., Europe and emerging markets adds medium geographic risk, while regulatory exposure in the building‑products sector is moderate. Overall, the stock appears cheap but is burdened by operational losses and high volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram with line above signal
  • Increasing trading volume
  • Price above 20‑day SMA providing near‑term support

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • DCF suggests modest undervaluation relative to current price
  • Low price‑to‑book and price‑to‑sales ratios
  • Persistent negative earnings and high debt‑to‑equity

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Ongoing operating losses and negative cash flow
  • High leverage and limited financial flexibility
  • Extreme volatility and liquidity constraints limiting upside potential

Key Metrics & Analysis

Financial Health

Revenue Growth-3.50%
Profit Margin-34.61%
P/E Ratio-1.0
ROE-66.71%
ROA-6.51%
Debt/Equity97.97
P/B Ratio0.2
Op. Cash Flow$-38029000
Free Cash Flow$8.4M
Industry P/E28.5

Technical Analysis

TrendNeutral
RSI43.5
Support$0.56
Resistance$1.58
MA 20$0.92
MA 50$1.63
MA 200$1.60
MACDBullish
VolumeIncreasing
Fear & Greed Index72.2

Valuation

Fair Value$1.06
GradeUndervalued
TypeValue

Risk Assessment

Beta0.90
Volatility169.83%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.